Related Experiment Video
Updated: Sep 2, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial amyloidosis: mechanisms and clinical manifestations
Giuseppe Vergaro1,2, Alberto Aimo1,2, Claudio Rapezzi3,4
1Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Insights
Cardiac amyloidosis (CA) involves atrial amyloidosis, an early sign linked to heart failure, atrial fibrillation, and clots. It can occur in isolation, impacting heart function and patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Research
- Biomedical Science
Background:
- Cardiac amyloidosis (CA) is a significant cause of heart failure.
- Amyloid deposition occurs throughout cardiac structures, not just the ventricles.
- Atrial involvement is an early manifestation of CA.
Purpose of the Study:
- To review the mechanisms of atrial amyloidosis in cardiac amyloidosis.
- To discuss the clinical relevance and implications of atrial amyloidosis.
- To highlight isolated atrial amyloidosis as a distinct entity.
Main Methods:
- Literature review of existing evidence on atrial amyloidosis.
- Synthesis of data on amyloid infiltration and its effects on atrial structures.
- Analysis of clinical associations, including atrial fibrillation and thromboembolism.
Main Results:
- Atrial amyloidosis contributes to diastolic dysfunction and atrial enlargement.
- It increases the risk of atrial fibrillation and thromboembolic events.
- Isolated atrial amyloidosis, linked to natriuretic peptide overproduction, can occur without ventricular disease.
Conclusions:
- Atrial amyloidosis is a crucial, often early, component of cardiac amyloidosis with significant clinical consequences.
- Understanding atrial involvement is key for managing heart failure and preventing complications.
- Further research into isolated atrial amyloidosis mechanisms and management is warranted.
Abstract:
Cardiac amyloidosis (CA) is now recognized as an important cause of heart failure. Increased wall thickness and diastolic dysfunction of the left ventricle are the most easily detectable manifestations of CA, but amyloid accumulates in all cardiac structures. Involvement of the left and right atria may be due to the haemodynamic effects of ventricular diastolic dysfunction, the effects of amyloid infiltration into the atrial wall, and the cardiotoxic damage of atrial cardiomyocytes by amyloid precursors. Atrial amyloidosis is an early manifestation of CA, and is associated with an increased risk of atrial fibrillation and thromboembolic events. Furthermore, atrial amyloidosis can be found even in the absence of systemic disease and ventricular involvement. This condition is named isolated atrial amyloidosis and is due to a local overproduction of atrial natriuretic peptide. In this review we summarize the evidence on the mechanisms and clinical relevance of atrial amyloidosis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests

